Notable Labs (NASDAQ:NTBL – Free Report) had its target price decreased by Chardan Capital from $7.00 to $5.00 in a research report report published on Thursday morning, Benzinga reports. Chardan Capital currently has a buy rating on the stock. Separately, JMP Securities reiterated a market outperform rating and set a $9.00 target price on shares […]
JMP Securities reaffirmed their market outperform rating on shares of Notable Labs (NASDAQ:NTBL – Free Report) in a research note issued to investors on Monday morning, Benzinga reports. They currently have a $9.00 price objective on the stock. Separately, Chardan Capital lowered their price objective on Notable Labs from $9.00 to $7.00 and set a […]
Notable Labs Reports 2023 Financial Results and Provides a Business Update finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Notable Labs Presents the Design Plan for the PPMP-Enabled Phase 2 Trial with Volasertib for Relapsed/Refractory AML at AACR 2024 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.